Codexis signs agreement with siRNA drug developer to evaluate ECO Synthesis platform
The companies will compare enzymatic stereo-defined oligonucleotide fragments with solid-phase synthesis for purity, quality and ligation performance.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
The companies will compare enzymatic stereo-defined oligonucleotide fragments with solid-phase synthesis for purity, quality and ligation performance.